Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial

The requested reference [70c116cf7f42bffe40406b5650c6bb53063ff609] no longer exists in our database. It has been replaced by the current reference: [ad0e426fe6e7dc5884237938fb0e43ae0b638651]

Authors
Category Primary study
Year 1997
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Compared with t-PA, reperfusion by primary PTCA improves clinical outcomes with similar or reduced costs.
Epistemonikos ID: 5ec130aff43c79743c4cd6254803acad11cf4600
First added on: Apr 19, 2023